• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Omapatrilat

CAS No. 167305-00-2

Omapatrilat ( BMS-186716 )

产品货号. M12553 CAS No. 167305-00-2

金属蛋白酶 ACE 和 NEP 的有效双重抑制剂,Ki 分别为 0.64 nM 和 0.45 nM。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥664 有现货
50MG ¥4609 有现货
100MG ¥8068 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Omapatrilat
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    金属蛋白酶 ACE 和 NEP 的有效双重抑制剂,Ki 分别为 0.64 nM 和 0.45 nM。
  • 产品描述
    A potent, dual inhibitor of the metalloproteases ACE and NEP with Ki of 0.64 nM and 0.45 nM, respectively; shows moderate activity against APP, and low activity against ECE1; causes significant inhibition of plasma ACE and increases plasma renin activity, reduces blood pressure in spontaneously hypertensive rats; orally active.Hypertension Discontinued.
  • 体外实验
    Omapatrilat exhibits high potency for NEP, NEP2 and ACE, moderate strong activity against APP, but low activity against ECE1 (Ki=0.45, 25, 0.64, 250 nM) . In vitro autoradiography using the specific NEP inhibitor radioligand 125I-RB104 and the specific ACE inhibitor radioligand 125I-MK351A show omapatril at (10 mg/kg) causes rapid and potent inhibition of renal NEP and ACE, respectively, for 24 h.
  • 体内实验
    Omapatrilat demonstrates excellent blood pressure lowering in a variety of animal models characterized by various levels of plasma renin activity and significantly potentiates urinary sodium, ANP, and cGMP excretion in a cynomolgus monkey assay. Omapatrilat decreases mean arterial pressure (MAP) approximately 40 mmHg below baseline from 10 to 24 h. Oral administration of omapatrilat at 100 μM/kg once daily results in a 38 mmHg decrease in systolic blood pressure at day three as compared to vehicle . Omapatrilat is widely used in experimental protocols related to hypertension and heart failure. Chronic oral administration of omapatrilat reduces aortic leakiness and atheroma formation with enhanced endothelial independent vasorelaxation to ANP. Omapatrilat causes significant inhibition of plasma ACE and increased plasma renin activity in rats.
  • 同义词
    BMS-186716
  • 通路
    Metabolic Enzyme/Protease
  • 靶点
    ACE
  • 受体
    ACE
  • 研究领域
    Cardiovascular Disease
  • 适应症
    Hypertension

化学信息

  • CAS Number
    167305-00-2
  • 分子量
    408.5349
  • 分子式
    C19H24N2O4S2
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO: ≥ 31 mg/mL
  • SMILES
    O=C([C@@H]1CCC[C@](N21)([H])SCC[C@H](NC([C@@H](S)CC3=CC=CC=C3)=O)C2=O)O
  • 化学全称
    7H-Pyrido[2,1-b][1,3]thiazepine-7-carboxylic acid, octahydro-4-[[(2S)-2-mercapto-1-oxo-3-phenylpropyl]amino]-5-oxo-, (4S,7S,10aS)-

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Robl JA, et al. J Med Chem. 1997 May 23;40(11):1570-7. 2. Fryer RM, et al. Br J Pharmacol. 2008 Mar;153(5):947-55. 3. Burrell LM, et al. Am J Hypertens. 2000 Oct;13(10):1110-6.
产品手册
关联产品
  • Abz-FR-K(Dnp)-P-OH

    Excellent angiotensin I-converting enzyme (ACE) substrate with a Km value of 4.0 μM and a kcat value of 210s-1.

  • H-Ile-Pro-Pro-OH

    H-Ile-Pro-Pro-OH, a milk-derived peptide, inhibits angiotensin-converting enzyme (ACE) with an IC50 of 5 μM.

  • Temocaprilat

    Temocaprilat 是一种血管紧张素转换酶 (ACE) 抑制剂。